Vanguard Group Inc Pacira Bio Sciences, Inc. Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
A detailed history of Vanguard Group Inc transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 5,084,831 shares of PCRX stock, worth $87.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,084,831
Previous 5,113,384
0.56%
Holding current value
$87.4 Million
Previous $149 Million
2.63%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding PCRX
# of Institutions
277Shares Held
48.5MCall Options Held
378KPut Options Held
1.53M-
Black Rock Inc. New York, NY8.01MShares$138 Million0.01% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.16MShares$37.2 Million0.16% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.07MShares$35.5 Million0.1% of portfolio
-
State Street Corp Boston, MA1.9MShares$32.7 Million0.0% of portfolio
-
Frontier Capital Management CO LLC1.84MShares$31.6 Million0.55% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $787M
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...